Skip to main content
Caplight Logo









Novotalk

Novotalk

Private
Bnei BrakHealthcare & Life Scienceshttps://www.novotalk.com/

Last Round

Seed

Oct 1, 2018

Company Overview

Novotalk is a health tech company that provides on-demand, self-directed speech and language teletherapy solutions for individuals with speech impairments.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Vertical SaaS

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

digital speech therapystuttering treatmentspeech therapy appteletherapydigital healthspeech fluencydigital therapeuticsDTxspeech analysisvirtual speech coachSaaSremote patient monitoringRPMspeech pathologyhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novotalk Comparables

Compare Novotalk with similar companies based on industry and business-model similarity.

Novotalk comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BeneTalk Ltd
84%
Iyaso
83%
Stamurai
82%

Novotalk Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 1, 2018
AcceleratorMay 23, 2017

Key People

Founding team and executive leadership

Avraham Sheinfeld

Chief Executive Officer of Novotalk Israel

Executive Team

Zohar Beeri

Chairman & CEO

Executive Team

Novotalk Investors

Notable investors and investment history

Novotalk investors
InvestorRounds
MassChallenge IsraelAccelerator
Mount Sinai VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2018

    Seed round led by Mount Sinai Ventures

  • May 23, 2017

    Received funding from MassChallenge Israel.

Novotalk Filings

Explore SEC and related filing metadata, where available.

Novotalk filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Novotalk's valuation, stock price, and market status.

Is Novotalk a public or private company?

Novotalk is a private company.

What is the current stock price of Novotalk?

Novotalk is a private company with no public stock price. No recent secondary market data is available.

How much is Novotalk worth (valuation)?

Valuation information for Novotalk is not publicly available.

Can I buy Novotalk stock?

Novotalk shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Novotalk's last funding round?

Novotalk's most recent funding round was Seed on October 1, 2018.

Who are the main investors in Novotalk?

Key investors in Novotalk include Mount Sinai Ventures.

Will Novotalk IPO soon?

No public IPO plans have been announced for Novotalk.

How can I track Novotalk secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novotalk's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBnei Brak
Employee Range4
Year Founded2014
Last FundingOct 1, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?